Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder
Tian, R.; Ge, T.; Liu, J. Z.; Lam, M.; Biogen Biobank team, ; Levey, D. F.; Gelernter, J.; Stein, M. B.; Tsai, E. A.; Huang, H.; Lencz, T.; Runz, H.; Chen, C.-Y.
Show abstract
Nearly two hundred common-variant depression risk loci have been identified by genome-wide association studies (GWAS)1-4. However, the impact of rare coding variants on depression remains poorly understood. Here, we present the largest to date exome analysis of depression based on 320,356 UK Biobank participants. We show that the burden of rare disruptive coding variants in loss-of-function intolerant genes is significantly associated with depression risk. Among 30 genes with false discovery rate (FDR) <0.1, SLC2A1, a blood-brain barrier glucose transporter underlying GLUT1 deficiency syndrome5-7, reached exome-wide significance (P=2.96e-7). Gene-set enrichment supports neuron projection development and muscle activities2, 3 as implicated in depression. Integrating exomes with polygenic risk revealed additive contributions from common and rare variants to depression risk. The burden of rare disruptive coding variants for depression overlapped with that of developmental disorder, autism and schizophrenia. Our study provides novel insight into the contribution of rare coding variants on depression and genetic relationships across developmental and psychiatric disorders.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Differential Chromatin Architecture and Risk Variants in Deep Layer Excitatory Neurons and Grey Matter Microglia Contribute to Major Depressive Disorder 96%
- Genome-wide analysis of binge-eating disorder identifies the first three risk loci and implicates iron metabolism 96%
- Genome-wide landscape of RNA-binding protein dysregulation reveals a major impact on psychiatric disorder risk 96%
Similar papers in this journal
- Genetic variants associated with cross-disorder and disorder-specific risk for psychiatric disorders are enriched at epigenetically active sites in peripheral lymphoid cells 95%
- Expanding the Genetic Architecture of Nicotine Dependence and its Shared Genetics with Multiple Traits: Findings from the Nicotine Dependence GenOmics (iNDiGO) Consortium 94%
- Polygenic architecture of brain structure and function, behaviors, and psychopathologies in children 94%
Similar papers in this journal
- Immunological Drivers and Potential Novel Drug Targets for Major Psychiatric, Neurodevelopmental, and Neurodegenerative Conditions 95%
- Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the Psychiatric Genomics Consortium 95%
- Functional and molecular characterization of suicidality factors using phenotypic and genome-wide data 95%
Similar papers in this journal
- Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression 96%
- Genetic mechanisms of 184 neuro-related proteins in human plasma 94%
- The shared genetic architecture and evolution of human language and musical rhythm 93%
Similar papers in this journal
- Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects on brain 96%
- Acetylated Chromatin Domains Link Chromosomal Organization to Cell- and Circuit-level Dysfunction in Schizophrenia and Bipolar Disorder 94%
- Connecting gene regulatory relationships to neurobiological mechanisms of brain disorders 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.